Welcome to MyStrategist, an online experience like no other in the medical device industry.

MedTech Strategist, the industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today.

Subscribe   Browse   Latest Issue
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe
View More
View More
Teaser Image
Business Strategies

Breathing New Life into Surgical Robots

  • 4 days ago
  • Contributing Writer

How can surgical robotics manufacturers deliver targeted innovations that dramatically improve patient outcomes and cost-efficiency in healthcare? It’s about developing procedural solutions that clearly surpass what humans can achieve. Clinical and financial benefits need to be tangible and measurable, so end-users can build a robust business case for investment. By Rob Morgan, VP Medical, Sagentia.

Subscribe now to read the full analysis
Subscribe

Registration is now open for the 7th annual Innovation Summit Dublin, April 21-23, 2020. The industry's most anticipated event will sell out. Register Today.

Register   Learn More
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe
View More
View More
Teaser Image
Start-Ups

ReThink Medical: Wrist-Worn Monitor Keeps Heart Failure Patients Out of the Hospital

  • 4 days ago
  • Mary Stuart

Now that large cardiology companies have demonstrated the value of measuring heart failure parameters with implantable devices, a new generation of companies hopes to do the same non-invasively with wearable devices. ReThink Medical has reduced a number of complex engineering challenges to a wearable wristband that gathers several physiological signals important for detecting worsening heart failure early.

Subscribe now to read the full analysis
Subscribe

Discover the opportunities and challenges that impact the global medtech regulatory and reimbursement community with MedTech Strategist Market Pathways.

Subscribe   Free Premier Issue   Learn More
Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe
View More
View More
Subscribe

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More
More From MedTech Strategist:

SinuSys Finds Great Promise in Kinder, Gentler Sinusitis Treatment

  • October 09, 2014
  • Mary Stuart
  • MedTech Strategist

While first-generation companies offering new interventions for the ENT market modeled themselves after interventional cardiology, next-generation company Sinusys Corp. took its cue from the pharma industry. Its implant for the treatment of sinusitis is based on an osmotic drug delivery technology and it promises to be gentler, more comfortable for the patient, and perhaps more benign to tissue than first-generation procedures.

Read Article